The Role of ERBB2/HER2 Tyrosine Kinase Receptor in the Regulation of Cell Death.

Biochemistry. Biokhimii︠a︡
A A DaksN A Barlev

Abstract

HER2 (Human Epidermal Growth Factor Receptor 2), also known as ERBB2, CD340, and Neu protooncogene, is a member of the epidermal growth factor receptor (EGRF) family. Members of the ERBB family, including HER2, activate molecular cascades that stimulate proliferation and migration of cancer cells, as well as their resistance to the anticancer therapy. These proteins are often overexpressed and/or mutated in various cancer types and represent promising targets for the anti-cancer therapy. Currently, anti-HER2 drugs have been approved for the treatment of several types of solid tumors. HER2-specific therapy includes monoclonal antibodies and low-molecular weight inhibitors of tyrosine kinase receptors, such as lapatinib, neratinib, and pyrotinib. In addition to the activation of molecular pathways responsible for cell proliferation and survival under stress conditions, HER2 directly regulates programmed cell death. Here, we review the studies focused on the involvement of HER2 in various signaling pathways and its role in the regulation of apoptosis.

References

May 11, 1991·Journal of Clinical Immunology·H M ShepardA Ullrich
Dec 1, 1991·Cell Regulation·P F JonesB A Hemmings
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·P F JonesB A Hemmings
Oct 6, 1998·Annual Review of Biochemistry·D A FrumanL C Cantley
Nov 13, 1998·Science·M H CardoneJ C Reed
Nov 26, 1998·The Journal of Biological Chemistry·K Du, M Montminy
Sep 22, 1999·European Journal of Biochemistry·S MasureA Richardson
Mar 14, 2000·The Journal of Biological Chemistry·B P ZhouM C Hung
Jan 12, 2001·Molecular and Cellular Biology·A H KimM V Chao
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
Mar 8, 2002·Cellular Signalling·Karleen M Nicholson, Neil G Anderson
Nov 25, 2003·The Journal of Biological Chemistry·Gerry MelinoKaren H Vousden
Dec 3, 2003·The Journal of Biological Chemistry·Han C DanJin Q Cheng
Mar 17, 2004·Cancer Treatment Reviews·Juan Angel Fresno VaraManuel González-Barón
Jul 27, 2004·Oncogene·Yujiang ZhangMong-Hong Lee
Aug 18, 2004·Genes & Development·Nissim Hay, Nahum Sonenberg
Jan 18, 2005·Journal of Cell Science·Inna LavrikPeter H Krammer
Dec 13, 2005·Neuron·W Bradley JacobsDavid R Kaplan
Feb 14, 2006·International Journal of Cancer. Journal International Du Cancer·Marie P PiechockiFulvio Lonardo
Jun 28, 2006·The Journal of Experimental Medicine·Han YouTak W Mak
Aug 19, 2006·Molecular Cell·Andrew G LiXuan Liu
Nov 28, 2006·Biochimica Et Biophysica Acta·James A McCubreyRichard A Franklin
Jan 15, 2008·Cell·Beth Levine, Guido Kroemer
Apr 19, 2008·The Journal of Biological Chemistry·Anne M StroheckerVincent L Cryns
Jan 27, 2009·Cellular Signalling·Regan M Memmott, Phillip A Dennis
Nov 26, 2009·Molecular Cancer Therapeutics·Toru AkiyamaPeter F M Choong
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Hyunsoo KimMark D Johnson
Aug 3, 2010·Antioxidants & Redox Signaling·Kristan E van der Vos, Paul J Coffer
Mar 5, 2011·Microbiology and Molecular Biology Reviews : MMBR·Marie Cargnello, Philippe P Roux
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Jun 29, 2011·Biochimica Et Biophysica Acta·Guri TzivionGopalakrishnan Ramakrishnan

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPases
RIP
ubiquitination

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.